Literature DB >> 7901494

Emergence of multiple drug resistance in Vibrio cholerae O1 El Tor from Ecuador.

E J Threlfall, B Said, B Rowe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7901494     DOI: 10.1016/0140-6736(93)92156-n

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Plasmidic extended-spectrum beta-lactamases in Vibrio cholerae O1 El Tor isolates in Argentina.

Authors:  Alejandro Petroni; Alejandra Corso; Roberto Melano; María Luisa Cacace; Ana María Bru; Alicia Rossi; Marcelo Galas
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

2.  Antibiotic resistance conferred by a conjugative plasmid and a class I integron in Vibrio cholerae O1 El Tor strains isolated in Albania and Italy.

Authors:  V Falbo; A Carattoli; F Tosini; C Pezzella; A M Dionisi; I Luzzi
Journal:  Antimicrob Agents Chemother       Date:  1999-03       Impact factor: 5.191

3.  Distribution and content of class 1 integrons in different Vibrio cholerae O-serotype strains isolated in Thailand.

Authors:  A Dalsgaard; A Forslund; O Serichantalergs; D Sandvang
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

4.  Randomized, double-blind placebo-controlled trial to evaluate the safety and immunogenicity of combined Salmonella typhi Ty21a and Vibrio cholerae CVD 103-HgR live oral vaccines.

Authors:  H Kollaritsch; E Furer; C Herzog; G Wiedermann; J U Que; S J Cryz
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

5.  Safety and immunogenicity of a live oral bivalent typhoid fever (Salmonella typhi Ty21a)-cholera (Vibrio cholerae CVD 103-HgR) vaccine in healthy adults.

Authors:  S J Cryz; J U Que; M M Levine; G Wiedermann; H Kollaritsch
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.